Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial
SHAWL
2 other identifiers
interventional
120
1 country
1
Brief Summary
This study is a randomized controlled trial among 120 recently displaced women to determine the effectiveness of a single-session Acceptance and Commitment Therapy (ACT) group therapy on prevention of development of mental health disorders or worsened mental health symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2024
CompletedFirst Posted
Study publicly available on registry
November 7, 2024
CompletedStudy Start
First participant enrolled
March 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2026
CompletedJanuary 16, 2026
January 1, 2026
10 months
November 6, 2024
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Anxiety symptoms
Anxiety symptoms will be assessed using the Mental Health Assessment Inventory (MHAI) anxiety subscore which has 4 items, and each item is rated on a 3-point Likert scale where "0" means "none of the time" and "3" means "almost all of the time." Total score on the subscale ranges from 0-12 with higher scores indicating greater symptoms of anxiety.
Baseline, 3 months
Depressive symptoms
Depressive symptoms will be assessed using the Mental Health Assessment Inventory (MHAI) depression subscore which has 6 items, and each item is rated on a 3-point Likert scale where "0" means "none of the time" and "3" means "almost all of the time." Total score on the subscale ranges from 0-36 with higher scores indicating greater symptoms of depression.
Baseline, 3 months
Secondary Outcomes (2)
Experiential avoidance
Baseline, 3-months
Psychological flexibility
Baseline, 3 months
Study Arms (2)
Behavioral: ACT Therapy
EXPERIMENTALParticipants randomized to this group will receive a single-session ACT intervention
Attention control
ACTIVE COMPARATORParticipants in the control group will receive minimally enhanced usual care to receive treatment as usual enhanced by a health information group session.
Interventions
The single-session ACT group intervention will involve a mixture of didactic instruction, discussion, metaphors, and experiential activities. ACT activities will help women notice and accept that negative thoughts, emotions, and experiences while being displaced by war are part of migratory and post-migratory life. ACT activities will also help them identify, reorient towards, and commit to values-consistent behaviors through effective goal-setting. The single-session will be approximately 3 hours long.
Usual care will be minimally enhanced by providing participants with an educational information session that provides information on health promotion.
Eligibility Criteria
You may qualify if:
- Age 18 or over
- Identify as a displaced woman within one year of migration
- Endorsing mild to moderate depressive symptoms (subscale score between 3 and 7) and/or anxiety symptoms (subscale score between 2 and 6) on the Mental Health Assessment Inventory (MHAI) but not exceeding the maximum score for either subscale (i.e., not exceeding 7 on the depressive symptoms subscale and not exceeding 6 on the anxiety symptoms subscale)
- Ability to provide informed consent
- Speak Ukrainian or Russian
You may not qualify if:
- Diagnosis of a depressive or anxiety disorder, or symptoms necessitating urgent referral for evaluation of suicidal or homicidal ideation
- Receipt of psychiatric care for depression or anxiety in the past 5 years
- A severe medical problem that inhibits ability to participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Medical Centerlead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Alliance for Public Health
Kyiv, Ukraine
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karsten Lunze, MD DrPH MPH
CABUSchool of Medicine, General Internal Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2024
First Posted
November 7, 2024
Study Start
March 27, 2025
Primary Completion
January 10, 2026
Study Completion
January 10, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share